Gram Research analysis shows that supervised resistance training is safe and effective for colorectal cancer survivors, improving muscle strength and physical function within 10 weeks. A 2026 randomized controlled trial of 27 cancer survivors found that both exercise-plus-creatine and exercise-plus-placebo groups showed modest improvements in strength and physical performance scores, with no serious adverse events reported. The creatine supplement provided no additional benefit beyond the exercise itself.
A new study tested whether cancer survivors could safely do strength training exercises, either with or without a supplement called creatine. Researchers worked with 27 people who had finished colorectal cancer treatment. They did resistance exercises three times a week for 10 weeks, either in-person or online. Most people stuck with the program and felt stronger afterward. The study shows that supervised strength training is safe and helpful for cancer survivors, though the creatine supplement didn’t add extra benefits in this small trial.
Key Statistics
A 2026 randomized controlled trial published in PLoS ONE found that 24 of 27 colorectal cancer survivors (88.9%) completed a 10-week hybrid resistance training program, with both exercise groups showing improvements in muscle strength and physical function.
According to research reviewed by Gram, colorectal cancer survivors who completed supervised resistance training three times weekly for 10 weeks demonstrated improved Short Physical Performance Battery scores, with no serious adverse events reported across all 27 participants.
A 2026 pilot study of 27 cancer survivors found that creatine supplementation (5 grams daily) did not provide additional strength improvements beyond resistance exercise alone, suggesting exercise is the primary therapeutic factor.
In a 2026 trial of colorectal cancer survivors, adherence to both resistance training and supplementation exceeded 85%, and participants reported high acceptability for hybrid in-person and virtual training formats.
The Quick Take
- What they studied: Can colorectal cancer survivors safely do strength training exercises, and does adding a creatine supplement help them get stronger?
- Who participated: 27 adults who had finished chemotherapy treatment for colorectal cancer. They were split into two groups: one doing exercises with creatine supplement (13 people) and one doing exercises with a placebo (14 people).
- Key finding: Both groups improved their muscle strength and physical function after 10 weeks of resistance training. The creatine supplement didn’t provide additional benefits beyond the exercise itself.
- What it means for you: If you’re a colorectal cancer survivor, supervised strength training appears safe and can help you regain strength and physical ability. Talk to your doctor before starting any new exercise program.
The Research Details
This was a randomized controlled trial, which is a gold-standard research design. Researchers recruited 27 cancer survivors and randomly assigned them to two groups. One group did resistance exercises (weight training) three times per week while taking 5 grams of creatine supplement daily. The other group did the same exercises but took a placebo (fake supplement) instead. The program lasted 10 weeks and combined in-person training sessions with virtual (online) sessions. Before and after the program, researchers measured muscle strength, body composition, and physical function using standard tests.
Cancer survivors often experience weakness and loss of muscle mass during and after treatment. This study was important because it tested whether a practical, hybrid training approach (mixing in-person and online sessions) could be feasible and safe for this vulnerable population. Understanding what works helps doctors and trainers design better recovery programs.
This was a well-designed pilot study with good retention (89% of participants completed it) and strong adherence to the exercise program (over 85% completion). However, the sample size was small (27 people), which limits how much we can generalize the findings. The study was published in PLoS ONE, a peer-reviewed journal. No serious safety problems occurred, which is reassuring.
What the Results Show
The study successfully demonstrated that a hybrid resistance training program is feasible and acceptable for colorectal cancer survivors. Recruitment was challenging—only 27 of 410 assessed individuals enrolled (6.6%)—but retention was excellent with 24 of 27 participants completing the full 10 weeks. Both the exercise-plus-creatine group and the exercise-plus-placebo group showed improvements in muscle strength and physical function scores. Participants reported high satisfaction with both the in-person and virtual training components, indicating the hybrid approach was well-received. No serious adverse events were reported, confirming the program’s safety profile.
Both groups demonstrated modest improvements in Short Physical Performance Battery (SPPB) scores, which measure balance, walking speed, and ability to stand from a chair—all important for daily living. Interestingly, the creatine supplement group did not show significantly better results than the placebo group, suggesting that the exercise itself was the primary driver of improvements rather than the supplement.
Previous research has shown that cancer survivors benefit from exercise, but this study adds important evidence about hybrid training models and confirms safety in this specific population. The finding that creatine didn’t provide additional benefit differs from some studies in non-cancer populations, possibly because cancer survivors have unique physiological responses to supplementation.
The main limitation is the small sample size (27 people), which makes it harder to detect differences between groups. The short duration (10 weeks) may not capture long-term benefits. The study had difficulty recruiting participants (only 6.6% of those screened enrolled), which may mean the results apply mainly to people willing and able to commit to structured exercise. Different types of colorectal cancer and varying treatment histories weren’t analyzed separately.
The Bottom Line
Colorectal cancer survivors should consider supervised resistance training as part of their recovery plan (moderate confidence level). The hybrid in-person and virtual format appears practical and effective. Creatine supplementation is not necessary to see benefits from exercise (moderate confidence). Always consult your oncologist before starting a new exercise program.
This research is most relevant for colorectal cancer survivors who have completed chemotherapy and want to regain strength. It’s also important for oncologists, physical therapists, and cancer rehabilitation specialists designing recovery programs. People with other cancer types may benefit, but this study specifically tested colorectal cancer survivors.
Participants saw improvements in strength and physical function within 10 weeks. Realistic expectations are modest but meaningful improvements in the first 2-3 months, with potentially greater gains with longer-term training.
Frequently Asked Questions
Is it safe for cancer survivors to do weight training?
Yes, according to a 2026 study of 27 colorectal cancer survivors, supervised resistance training was safe with no serious adverse events reported. Participants improved strength within 10 weeks. Always consult your oncologist before starting.
Does creatine supplement help cancer survivors build muscle?
A 2026 trial found creatine supplementation provided no additional benefit beyond exercise alone in cancer survivors. The resistance training itself drove the strength improvements, not the supplement.
How often should cancer survivors do strength training?
Research shows three sessions per week for 10 weeks produced measurable improvements in strength and physical function for colorectal cancer survivors. This frequency appears both feasible and effective for this population.
Can cancer survivors do online exercise training instead of in-person?
A 2026 study found that a hybrid approach combining in-person and virtual sessions was highly acceptable and feasible for cancer survivors, with 89% completion rates and strong adherence over 10 weeks.
How quickly will cancer survivors see strength improvements?
According to a 2026 trial of 27 colorectal cancer survivors, measurable improvements in muscle strength and physical function appeared within the 10-week program period, though gains were described as modest.
Want to Apply This Research?
- Track weekly resistance training sessions completed (target: 3 per week) and monitor strength improvements using simple metrics like number of repetitions or weight lifted in key exercises.
- Set a weekly reminder for three resistance training sessions and log completion in the app. Start with bodyweight exercises or light weights and gradually increase resistance as strength improves.
- Monthly check-ins to assess physical function improvements (ability to climb stairs, stand from a chair, walk distances). Track subjective energy levels and fatigue alongside workout completion.
This research represents preliminary findings from a small pilot study and should not replace medical advice from your oncology team. Before starting any exercise program, resistance training, or supplement regimen, consult with your oncologist or healthcare provider, especially if you’re currently undergoing cancer treatment or have recently completed treatment. Individual responses to exercise and supplements vary based on cancer type, treatment history, and overall health status. This article is for educational purposes and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.